IRIS - Res&Arch Institutional Research Information System - Research & Archive

FALINI, Brunangelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.817
EU - Europa 8.004
AS - Asia 7.148
SA - Sud America 1.244
Continente sconosciuto - Info sul continente non disponibili 860
AF - Africa 187
OC - Oceania 11
Totale 28.271
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.496
SG - Singapore 3.326
IT - Italia 1.599
IE - Irlanda 1.247
UA - Ucraina 1.105
SE - Svezia 1.001
RU - Federazione Russa 998
CN - Cina 947
BR - Brasile 945
HK - Hong Kong 800
VN - Vietnam 777
DE - Germania 484
FI - Finlandia 431
FR - Francia 417
KR - Corea 337
GB - Regno Unito 278
CA - Canada 174
IN - India 142
BD - Bangladesh 138
TR - Turchia 127
AR - Argentina 99
IQ - Iraq 89
NL - Olanda 84
MX - Messico 79
UZ - Uzbekistan 68
PL - Polonia 63
JP - Giappone 55
AT - Austria 51
CO - Colombia 50
ZA - Sudafrica 47
CH - Svizzera 44
ID - Indonesia 44
PK - Pakistan 44
BE - Belgio 42
EC - Ecuador 42
VE - Venezuela 36
ES - Italia 34
SA - Arabia Saudita 32
PH - Filippine 30
CZ - Repubblica Ceca 29
MA - Marocco 28
LB - Libano 23
JO - Giordania 22
ET - Etiopia 20
PE - Perù 18
EG - Egitto 17
CL - Cile 16
GR - Grecia 16
MY - Malesia 15
BO - Bolivia 14
JM - Giamaica 14
LT - Lituania 13
OM - Oman 13
PY - Paraguay 13
AZ - Azerbaigian 12
KE - Kenya 12
KZ - Kazakistan 12
AE - Emirati Arabi Uniti 11
CR - Costa Rica 11
NP - Nepal 11
DZ - Algeria 10
RO - Romania 10
TH - Thailandia 10
TN - Tunisia 10
UY - Uruguay 10
PS - Palestinian Territory 9
PT - Portogallo 9
IL - Israele 8
EU - Europa 7
HU - Ungheria 7
KG - Kirghizistan 7
PA - Panama 7
AL - Albania 6
AU - Australia 6
BG - Bulgaria 6
GT - Guatemala 6
RS - Serbia 6
SC - Seychelles 6
SN - Senegal 6
SY - Repubblica araba siriana 6
AO - Angola 5
GE - Georgia 5
HN - Honduras 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
LA - Repubblica Popolare Democratica del Laos 4
QA - Qatar 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AM - Armenia 3
CI - Costa d'Avorio 3
HR - Croazia 3
LK - Sri Lanka 3
LV - Lettonia 3
NG - Nigeria 3
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
Totale 27.367
Salva come PNG Salva come JPEG
Città #
Singapore 2.328
Chandler 1.378
Dublin 1.246
San Jose 1.074
Hong Kong 794
Ashburn 712
San Mateo 665
Perugia 633
Jacksonville 580
Boardman 475
Dong Ket 428
Santa Clara 420
Moscow 354
Seoul 335
Altamura 308
Medford 283
Princeton 278
Lauterbourg 270
Wilmington 240
Beijing 218
Lawrence 213
Ann Arbor 198
Andover 190
Los Angeles 177
New York 172
Munich 153
Piscataway 128
Ho Chi Minh City 116
Helsinki 115
The Dalles 111
Des Moines 99
Saint Petersburg 83
São Paulo 81
Hanoi 80
Turku 76
Dallas 72
Shanghai 69
Norwalk 64
Council Bluffs 61
Izmir 57
Rome 57
Orem 53
Houston 50
Woodbridge 49
Frankfurt am Main 48
Tokyo 48
Falls Church 47
London 44
Montreal 43
Amsterdam 41
Brussels 40
Baghdad 39
Brooklyn 39
Nuremberg 38
San Paolo di Civitate 38
Phoenix 37
Tashkent 36
Chicago 35
Milan 35
Redmond 34
Belo Horizonte 33
Johannesburg 33
Ottawa 33
Rio de Janeiro 33
Warsaw 32
San Francisco 30
Toronto 30
Denver 29
Atlanta 27
Chennai 27
Manchester 27
Redwood City 27
Mexico City 26
Stockholm 24
Bologna 22
Charlotte 21
Haiphong 20
Ankara 19
Addis Ababa 18
Amman 18
Boston 18
Foligno 18
Dhaka 17
Lahore 17
Auburn Hills 16
Curitiba 16
Dearborn 16
Guangzhou 16
Philadelphia 16
Buffalo 15
Jakarta 15
Medellín 15
Poplar 15
Barnet 14
Brasília 14
Falkenstein 14
Mumbai 14
Vienna 14
Ficarazzi 13
Secaucus 13
Totale 17.020
Salva come PNG Salva come JPEG
Nome #
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 184
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 182
BCOR gene alterations in hematological diseases 182
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 174
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 165
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 160
Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction. 151
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 151
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. 150
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 150
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial 150
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 145
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 145
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 145
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 144
Acute leukaemia immunophenotyping in bone-marrow routine sections. 142
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 141
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 139
Mutant NPM1 Maintains the Leukemic State through HOX Expression 135
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features 133
Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita 133
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 133
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. 132
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. 130
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics] 130
Choroidal vasculature analysis in MEK inhibitor-associated retinopathy 130
"Designed" grafts for HLA-haploidentical stem cell transplantation. 129
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 128
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 127
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 124
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells 124
Anaplastic large cell lymphoma: pathological, molecular and clinical features. 123
Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification 123
Genomics of Hairy cell leukemia 122
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 122
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 121
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 121
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 119
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 119
EML4-ALK rearrangement in non-small-cell lung cancer and non-tumor lung tissues. 118
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance 118
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 118
Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease 117
L’esclusione degli anziani dai trial clinici in corso sul trattamento delle neoplasie ematologiche 117
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 117
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 117
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 116
Antigen retrieval techniques in immunohistochemistry: comparison of different methods 116
Aggressive lymphomas: a convenient concept or an anatomo-pathological reality? 115
The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues. 114
T regulatory cell separation for clinical application. 114
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 113
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 113
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia 112
Nucleophosmin regulates the stability and transcriptional activity of p53. 112
Minimal residual disease levels assessed by NPM1 mutation specific RQ-PCR provide important prognostic information in AML. 112
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 112
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 112
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease 112
Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23). 112
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 112
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 111
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 111
Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. 110
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 110
THE BRAF-MEK-ERK PATHWAY IN HAIRY CELL LEUKEMIA: A COMPREHENSIVE DISSECTION IN PRIMARY LEUKEMIC CELLS OF ITS BIOLOGICAL AND THERAPEUTIC RELEVANCE 110
BRAF mutations in hairy-cell leukemia. 109
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice. 109
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 109
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity 109
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy 109
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 108
Primay large B-cell lymphoma (PLBCL) of the retroperitoneum: a heterogeneous group of neoplasms, some of which mimic PLBCL of the mediastinum. 108
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 108
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 108
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 108
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. 107
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 107
Richter's transformation in the heart 107
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 106
Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas 105
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 105
Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma. 104
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. 104
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin 104
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 104
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases 103
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 103
Biological and therapeutic relevance of the BRAF-MEK-ERK pathway in hairy cell leukemia 103
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 103
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 103
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT) 102
Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity 102
CHARACTERIZATION OF A NEW MONOCLONAL ANTIBODY (PG-M3) DIRECTED AGAINST THE AMINOTERMINAL PORTION OF THE PML GENE PRODUCT: IMMUNOCYTOCHEMICAL EVIDENCE FOR HIGH EXPRESSION OF PML PROTEINS ON ACTIVATED MACROPHAGES, ENDOTHELIAL CELLS, AND EPITHELIA 102
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 102
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 102
Quantitative detection of NPM1 mutations as marker of minimal residual disease (MRD) in the large majority of AML with normal karyotype 101
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin 101
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray 101
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. 101
Totale 12.096
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.229 0 0 79 182 102 41 30 741 68 151 429 406
2022/20234.459 313 797 42 351 364 512 6 208 1.592 57 161 56
2023/20241.616 121 175 88 47 16 20 376 30 137 47 278 281
2024/20254.194 115 443 172 125 565 162 225 365 867 237 568 350
2025/20269.200 760 558 382 1.046 1.230 876 1.513 491 1.148 843 240 113
2026/2027806 232 340 234 0 0 0 0 0 0 0 0 0
Totale 28.271